SAB Biotherapeutics SABS
NASDAQ SABS
$2.86 -0.18 (-6.09%)
As of: Oct 23, 2026 · 1:56 PM EDT

SAB Biotherapeutics (SABS) Amortization of Deferred Charges (2021 - 2026)

Updated

Analysis

SAB Biotherapeutics (SABS) Amortization of Deferred Charges (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,132.13 Bn 1,100.72 Bn 19.71 Bn
2 Johnson & Johnson 634.87 Bn 554.73 Bn 17.30 Bn
3 AbbVie 506.59 Bn 479.70 Bn 12.70 Bn
4 Merck 357.59 Bn 311.97 Bn 12.21 Bn
5 Novartis Ag 291.51 Bn 255.50 Bn 11.24 Bn
6 Astrazeneca 265.00 Bn 238.69 Bn 12.86 Bn
7 Amgen 238.17 Bn 193.57 Bn 7.24 Bn
8 Gilead Sciences 195.18 Bn 169.37 Bn 6.22 Bn
9 Pfizer 171.20 Bn 117.84 Bn 10.94 Bn
10 SAB Biotherapeutics 227.70 Mn -189.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22,000.00
Mar 31, 2026 22,000.00
Dec 31, 2025 34,883.00
Sep 30, 2025 22,000.00
Jun 30, 2025 22,000.00
Mar 31, 2025 22,000.00
Dec 31, 2024 34,882.00
Sep 30, 2024 22,000.00
Jun 30, 2024 22,000.00
Mar 31, 2024 22,000.00
Dec 31, 2023 29,779.00
Sep 30, 2023 22,000.00
Jun 30, 2023 23,000.00
Mar 31, 2023 25,000.00
Dec 31, 2022 24,716.00
Sep 30, 2022 24,717.00
Jun 30, 2022 31,809.00
Mar 31, 2022 41,207.00
Dec 31, 2021 41,206.00
Sep 30, 2021 41,259.00
API Access

SAB Biotherapeutics Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=SABS&period=max&api_key=YOUR_API_KEY